MPWT
CBAY

MassMutual Private Wealth & Trust’s Cymabay Therapeutics CBAY Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-288
Closed -$1K – 1899
2022
Q3 		$1K Hold
288
– – ﹤0.01% 1588
2022
Q2 		$1K Buy
+288
New +$688 ﹤0.01% 1467
2022
Q1 		– Sell
-178
Closed -$1K – 1669
2021
Q4 		$1K Buy
+178
New +$676 ﹤0.01% 1351

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MassMutual Private Wealth & Trust's CBAY Position: Q4 2022 in Review

MassMutual Private Wealth & Trust sold out of Cymabay Therapeutics (CBAY) in Q4 2022, closing a stake of 288 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in CBAY in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 118 funds tracked by Wall St. Rank hold CBAY as of Q4 2022.

  • MassMutual Private Wealth & Trust reported no remaining Cymabay Therapeutics position as of Q4 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 288 Cymabay Therapeutics shares in Q4 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Cymabay Therapeutics in Q4 2021 and held it in 3 quarters.
  • MassMutual Private Wealth & Trust's Cymabay Therapeutics position peaked at $1K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2022, filed 6 Jan 2023.